Time-honored Brand Guangyuyuan: Inheritance and Innovation of Chinese Brands Post date May 10, 2022 — 13:21 Post Lock Read More
R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More
A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More
A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More
China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.20% China Universal Post date May 6, 2022 — 08:59 Post Lock Read More
China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.20% China Universal Post date May 6, 2022 — 08:58 Post Lock Read More
Sector Changes New Crown Treatment Drug Sales Hot New Crown Drug Concept Stocks Strengthened_Stock News_Market_Zhongjin Online Post date May 5, 2022 — 12:19 Post Lock Read More
A-share lunch review: Shanghai index rose 1.11% in half a day, and the turnover of Ningde era exceeded 17 billion yuan Post date May 5, 2022 — 11:56 Post Lock Read More
Guang Yuyuan: State-owned assets show vitality, and operating performance in the first quarter has grown significantly-Business Life-Finance Post date May 1, 2022 — 14:32 Post Lock Read More
[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks will increase in revenue and net profit, and BeiGene will become the "loss king"-Stock Channel-Hexun.com Post date May 1, 2022 — 04:00 Post Lock Read More
[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm Post date May 1, 2022 — 04:00 Post Lock Read More
China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.63% China Universal Post date April 30, 2022 — 08:40 Post Lock Read More
China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.63% China Universal Post date April 30, 2022 — 08:38 Post Lock Read More
Guang Yuyuan: State-owned assets show vitality, and operating performance in the first quarter has grown significantly_Oriental Fortune Net Post date April 29, 2022 — 21:09 Post Lock Read More
Guang Yuyuan: State-owned assets show vitality, and operating performance in the first quarter has grown significantly Post date April 29, 2022 — 21:08 Post Lock Read More
4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm Post date April 25, 2022 — 18:15 Post Lock Read More
[Graphic Quarterly Report] China Universal CSI Traditional Chinese Medicine Index (LOF) A Fund 2022 First Quarterly Report Review_Oriental Fortune Network Post date April 24, 2022 — 12:05 Post Lock Read More
The main capital of 2.224 billion yuan is withdrawn from the pharmaceutical and biological sector today_ Oriental Fortune Net Post date April 22, 2022 — 18:31 Post Lock Read More
Yunnan Baiyao, a "mid-life crisis" interface news of a white horse stock JMedia Post date April 20, 2022 — 23:07 Post Lock Read More
Yunnan Baiyao, a "mid-life crisis" of a white horse stock Yunnan Baiyao_Sina Finance_Sina Network Post date April 20, 2022 — 21:13 Post Lock Read More
Caishen.CoCaishen.Co